Search
Fourteen months after hedge fund investor Bill Ackman denounced Herbalife’s business model as an elaborate scheme preying upon consumers, The New York Times has brought forward extensive information on Ackman’s carefully orchestrated campaign and its tactics.
Both the U.S. Securites and Exchange Commission and the Federal Trade Commission have responded to Sen. Edward Markey’s letters concerning global nutrition company Herbalife.
On Friday, Herbalife executives hosted congressional staffers for a Washington briefing on Herbalife’s business model and the wider direct selling industry.
It’s been almost a year since Bill Ackman announced his short position on Herbalife (HLF—NYSE). With much media fanfare, he gave a 300+ slide presentation explaining the validity of his thesis.
A recent Bloomberg report indicates that Herbalife executives have been taking notes amid Bill Ackman’s year-long campaign attacking the company’s business model and lobbying federal agencies to investigate its practices.
As Pershing Square’s Bill Ackman continued his attack on Herbalife in this morning’s session of the Robin Hood Investors Conference, the global nutrition company’s stock gained more than 5 percent, reaching $71.91 by midday.
As hedge-fund investor Bill Ackman continued his disparaging commentary on Herbalife at a recent appearance at Oxford University, Rafael A. Fantauzzi—who serves as President & CEO of the National Puerto Rican Coalition (NPRC) and a Board Member of the Hispanic Association on Corporate Responsibility (HACR)—offered a very different perspective on the company.
Global nutrition company Herbalife has been the subject of countless headlines since activist investor Bill Ackman’s Pershing Square fund announced a $1-billion short on the company’s stock.
In Canada’s Financial Post, contributor Armina Ligaya recently provided an in-depth look at legitimate direct selling practices in contrast to how illegal schemes conduct business.
The strong 2nd quarter and July performance of many publicly held direct selling companies sends strong signals regarding the current state of direct selling and the future. After taking the brunt of a vicious short seller attack last year, Herbalife’s share price has rebounded significantly.
Shares in Herbalife reached a 52-week high of $66.23 on Tuesday, following Monday’s announcement of double-digit sales growth in the second quarter.
When Bill Ackman of Pershing Square Capital Management launched his attack against Herbalife at the close of 2012, he apparently hoped to take down a very large, very successful company that he alleged was using a questionable business model.